R 0018/11 of 22.11.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:R001811.20121122
- Date of decision
- 22 November 2012
- Case number
- R 0018/11
- Petition for review of
- T 0007/07 2011-07-07
- Application number
- 00953387.8
- IPC class
- A61K 31/565A61K 31/585A61P 15/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
- Applicant name
- Bayer Pharma Aktiengesellschaft
- Opponent name
- Hexal AG
Intervener: Ladee Pharma Baltics UAB - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(4)European Patent Convention Art 113European Patent Convention Art 115European Patent Convention R 106European Patent Convention R 109
- Keywords
- Petition clearly unallowable (yes)
- Catchword
- -
ORDER
For these reasons it is decided that:
The petition for review is unanimously rejected as clearly unallowable.